Amyloidosis
1 paper
- Human trial1
Latest
46 in 12 monthsCardiology and Therapy
Neurologic Stability During Tafamidis Treatment in Transthyretin Amyloidosis with a Mixed Phenotype: A Multicenter Real-World Study
Cohort study of 67 peopleInterventions
PLOS One
Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study
Non-randomised trial in 7 peopleDapagliflozin
Neurobiology of Aging
Neuropathology of centenarians and supercentenarians: An autopsy study
Cohort study of 24 peoplePopulations
European Heart Journal Cardiovascular Imaging
Prospective Systematic Screening for Transthyretin Amyloid Cardiomyopathy in Cardiology Inpatients With Left Ventricular Hypertrophy: the IMPACT Study
Cohort study of 400 peopleCardiomyopathy
Molecular Neurobiology
Circulating Metabolite Signatures Associated With Amyloid Positivity, Cognitive Performance and Plasma P-tau181 Levels in Cognitively Unimpaired Older Adults
Cross-sectional study of 100 peoplep-tau181
Cardiology and Therapy
Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy
Cohort study of 1,924 peopleInterventions
Amyloid
Frailty is a mortality risk factor in tafamidis-treated patients with transthyretin cardiac amyloidosis
Cohort study of 410 peopleCardiac amyloidosis
European Heart Journal Digital Health
Point-of-care echocardiography screening for hypertrophic cardiomyopathy using automated deep-learning analysis
Cohort study of 73,598 peopleHypertrophic cardiomyopathy